Literature DB >> 18805895

Role of CYP epoxygenases in A2A AR-mediated relaxation using A2A AR-null and wild-type mice.

Mohammed A Nayeem1, Samuel M Poloyac, John R Falck, Darryl C Zeldin, Catherine Ledent, Dovenia S Ponnoth, Habib R Ansari, S Jamal Mustafa.   

Abstract

We hypothesized that A2A adenosine receptor (A2A AR) activation causes vasorelaxation through cytochrome P-450 (CYP) epoxygenases and endothelium-derived hyperpolarizing factors, whereas lack of A2A AR activation promotes vasoconstriction through Cyp4a in the mouse aorta. Adenosine 5'-N-ethylcarboxamide (NECA; 10(-6) M), an adenosine analog, caused relaxation in wild-type A2A AR (A2A AR+/+; +33.99 +/- 4.70%, P < 0.05) versus contraction in A2A AR knockout (A2A AR(-/-); -27.52 +/- 4.11%) mouse aortae. An A2A AR-specific antagonist (SCH-58261; 1 microM) changed the NECA (10(-6) M) relaxation response to contraction (-35.82 +/- 4.69%, P < 0.05) in A2A AR+/+ aortae, whereas no effect was noted in A2A AR(-/-) aortae. Significant contraction was seen in the absence of the endothelium in A2A AR+/+ (-2.58 +/- 2.25%) aortae compared with endothelium-intact aortae. An endothelial nitric oxide synthase inhibitor (N-nitro-L-arginine methyl ester; 100 microM) and a cyclooxygenase inhibitor (indomethacin; 10 microM) failed to block NECA-induced relaxation in A2A AR+/+ aortae. A selective inhibitor of CYP epoxygenases (methylsulfonyl-propargyloxyphenylhexanamide; 10 microM) changed NECA-mediated relaxation (-22.74 +/- 5.11% at 10(-6) M) and CGS-21680-mediated relaxation (-18.54 +/- 6.06% at 10(-6) M) to contraction in A2A AR+/+ aortae, whereas no response was noted in A2A AR(-/-) aortae. Furthermore, an epoxyeicosatrienoic acid (EET) antagonist [14,15-epoxyeicosa-5(Z)-enoic acid; 10 microM] was able to block NECA-induced relaxation in A2A AR+/+ aortae, whereas omega-hydroxylase inhibitors (10 microM dibromo-dodecenyl-methylsulfimide and 10 microM HET-0016) changed contraction into relaxation in A2A AR(-/-) aorta. Cyp2c29 protein was upregulated in A2A AR+/+ aortae, whereas Cyp4a was upregulated in A2A AR(-/-) aortae. Higher levels of dihydroxyeicosatrienoic acids (DHETs; 14,15-DHET, 11,12-DHET, and 8,9-DHET, P < 0.05) were found in A2A AR+/+ versus A2A AR(-/-) aortae. EET levels were not significantly different between A2A AR+/+ and A2A AR(-/-) aortae. It is concluded that CYP epoxygenases play an important role in A2A AR-mediated relaxation, and the deletion of the A2A AR leads to contraction through Cyp4a.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805895      PMCID: PMC2614586          DOI: 10.1152/ajpheart.01333.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  65 in total

Review 1.  Receptors for purines and pyrimidines.

Authors:  V Ralevic; G Burnstock
Journal:  Pharmacol Rev       Date:  1998-09       Impact factor: 25.468

2.  Contribution of cytochrome P-450 omega-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension.

Authors:  J C Frisbee; J R Falck; J H Lombard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

3.  Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids.

Authors:  N L Weintraub; X Fang; T L Kaduce; M VanRollins; P Chatterjee; A A Spector
Journal:  Am J Physiol       Date:  1999-11

Review 4.  Molecular mechanisms controlling nutritive blood flow: role of cytochrome P450 enzymes.

Authors:  D R Harder; R J Roman; D Gebremedhin
Journal:  Acta Physiol Scand       Date:  2000-04

5.  Gene expression in distinct regions of the heart.

Authors:  T Thum; J Borlak
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

6.  Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.

Authors:  C L Oltman; N L Weintraub; M VanRollins; K C Dellsperger
Journal:  Circ Res       Date:  1998-11-02       Impact factor: 17.367

7.  Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium.

Authors:  W Abebe; S R Makujina; S J Mustafa
Journal:  Am J Physiol       Date:  1994-05

8.  Adenosine produces pulmonary vasodilation in the perfused rabbit lung via an adenosine A2 receptor.

Authors:  R G Pearl
Journal:  Anesth Analg       Date:  1994-07       Impact factor: 5.108

9.  Role of PGI2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid.

Authors:  M Rosolowsky; W B Campbell
Journal:  Am J Physiol       Date:  1993-02

10.  14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells.

Authors:  M VanRollins; T L Kaduce; H R Knapp; A A Spector
Journal:  J Lipid Res       Date:  1993-11       Impact factor: 5.922

View more
  27 in total

1.  Role of ω-hydroxylase in adenosine-mediated aortic response through MAP kinase using A2A-receptor knockout mice.

Authors:  Dovenia S Ponnoth; Mohammed A Nayeem; Swati S Kunduri; Stephen L Tilley; Darryl C Zeldin; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

2.  Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.

Authors:  Maryam Sharifi Sanjani; Bunyen Teng; Thomas Krahn; Stephen Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-23       Impact factor: 4.733

3.  Modulation by salt intake of the vascular response mediated through adenosine A(2A) receptor: role of CYP epoxygenase and soluble epoxide hydrolase.

Authors:  Mohammed A Nayeem; Darryl C Zeldin; Matthew A Boegehold; Christophe Morisseau; Anne Marowsky; Dovenia S Ponnoth; Kevin P Roush; John R Falck
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-04-28       Impact factor: 3.619

4.  Drug Delivery and Nanoformulations for the Cardiovascular System.

Authors:  W J Geldenhuys; M T Khayat; J Yun; M A Nayeem
Journal:  Res Rev Drug Deliv       Date:  2017-03-07

5.  Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγ.

Authors:  Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; Mohammed A Nayeem
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-08-03       Impact factor: 3.619

6.  Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis.

Authors:  Yasmeen Q Rizvi; Chander S Mehta; Adebayo Oyekan
Journal:  Vascul Pharmacol       Date:  2013-09-17       Impact factor: 5.773

7.  Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.

Authors:  Hicham Labazi; Stephen L Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  J Pharmacol Exp Ther       Date:  2015-12-30       Impact factor: 4.030

8.  Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A1 receptor-dependent contraction in mouse mesenteric arteries: role of ATP-sensitive K+ channels.

Authors:  Vishal R Yadav; Ka L Hong; Darryl C Zeldin; Mohammed A Nayeem
Journal:  Mol Cell Biochem       Date:  2016-09-15       Impact factor: 3.396

9.  Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.

Authors:  Mohammed A Nayeem; Isha Pradhan; S Jamal Mustafa; Christophe Morisseau; John R Falck; Darryl C Zeldin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-11-14       Impact factor: 3.619

10.  Angiotensin II stimulation alters vasomotor response to adenosine in mouse mesenteric artery: role for A1 and A2B adenosine receptors.

Authors:  Vishal R Yadav; Mohammed A Nayeem; Stephen L Tilley; S Jamal Mustafa
Journal:  Br J Pharmacol       Date:  2015-10-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.